Stem Cell & Exosome Therapy
A clinician-guided approach to regenerative medicine focused on careful evaluation, individualized planning, and informed decision-making. Explore the science, potential applications, limitations, and safety considerations before deciding whether a regenerative therapy consultation is right for you.
Regenerative medicine is an evolving field. Treatment suitability, product status, expected outcomes, and risks should be reviewed with a qualified healthcare professional.
Understanding stem cells and exosomes.
Stem cells and exosomes are often discussed together, but they are not the same thing. Understanding that distinction is an important part of evaluating regenerative medicine responsibly.
Stem Cell Therapy
Stem cells are cells with the ability to self-renew and, depending on their type, develop into more specialized cells. Certain stem-cell products have established medical uses, while many other marketed regenerative applications remain investigational or unapproved.
- Focuses on cellular biology and tissue-related research
- Product source and regulatory status matter
- Potential benefits depend on the specific condition and therapy
- Requires careful discussion of evidence, alternatives, and risks
Exosome Therapy
Exosomes are tiny extracellular vesicles released by cells. They can carry proteins, lipids, and genetic material involved in cell-to-cell communication, which is why they are being actively studied in regenerative medicine.
- Research centers on cellular signaling and communication
- Not the same as receiving living stem cells
- Clinical claims should be evaluated cautiously
- There are currently no FDA-approved exosome products
What regenerative medicine is trying to understand.
Regenerative medicine investigates ways to repair, replace, restore, or support damaged cells and tissues. The field includes established therapies as well as experimental approaches that are still being tested.
Repair and renewal
Researchers study how cells respond to injury, inflammation, aging, and disease, and how those biological processes might be influenced safely and predictably.
Cell-to-cell communication
Exosomes are one part of a complex signaling network. Their contents and effects can vary by cell source, preparation, dose, manufacturing process, and route of administration.
Research is not the same as proven treatment
Laboratory findings and early clinical studies can be promising, but they do not automatically establish that a therapy is safe or effective for a specific medical condition. Clinical evidence and regulatory status should be reviewed separately for each proposed use.
Questions worth answering before treatment.
A high-quality regenerative medicine consultation should help you understand exactly what is being proposed, why it is being considered, what evidence supports it, and what uncertainties remain.
What product is being used?
Ask about the source, manufacturer, processing, storage, and whether the product contains living cells, extracellular vesicles, or another biologic material.
What is its regulatory status?
Approval status can vary by product and intended use. Ask whether the proposed use is FDA approved, investigational, or otherwise subject to regulatory requirements.
What evidence supports it?
Look beyond testimonials. Discuss published clinical evidence, the quality of the data, realistic outcomes, and whether the evidence applies to your specific condition.
What are the alternatives?
A balanced discussion should also cover established treatment options, watchful waiting where appropriate, rehabilitation, medications, procedures, or specialist referral.
What are the risks?
Risk depends on the product, source, route, sterility, handling, patient factors, and treatment setting. These details should be discussed before consent.
What follow-up is provided?
Understand what happens after treatment, who manages concerns, how adverse effects are handled, and when additional medical evaluation may be needed.
A clear process from questions to next steps.
Regenerative care should begin with assessment rather than assumptions. The goal is to determine whether further evaluation is reasonable and to make sure you understand the potential benefits, uncertainties, and alternatives.
Start with your goals
Tell us what you are hoping to address and what treatments, specialists, or therapies you have already tried.
Review your health history
A clinician reviews relevant diagnoses, medications, allergies, previous procedures, and other factors that may affect suitability.
Discuss the evidence
We review what is known, what remains uncertain, potential risks, and whether referral or additional medical evaluation is appropriate.
Decide on next steps
If an option is appropriate, the next step is explained clearly. If it is not, other care pathways can be discussed.
Regenerative medicine deserves careful scrutiny.
The FDA regulates human cell and tissue products and continues to warn consumers about unapproved regenerative medicine products marketed for treating or curing a wide range of diseases. Product type, intended use, manufacturing, and regulatory pathway all matter.
Important regulatory note: The FDA states that there are currently no FDA-approved exosome products. It also cautions that many stem-cell products promoted for orthopedic, neurologic, cardiovascular, pulmonary, and other conditions have not been approved for those uses. This page is educational and does not promise that a regenerative product can treat, cure, or prevent any disease.
Personalized wellness care built around convenience.
Mobile IV of the Palm Beaches provides mobile IV therapy and wellness services across Palm Beach, the Treasure Coast, and surrounding South Florida communities. The team emphasizes personalized care, professional service, and a convenient patient experience.
What patients often ask about regenerative therapy.
No. Stem cells are living cells. Exosomes are small extracellular vesicles released by cells and involved in cellular communication. They differ in biology, manufacturing, proposed uses, and regulatory considerations.
The FDA states that there are currently no FDA-approved exosome products. Anyone considering an exosome product should ask about its regulatory status, source, manufacturing standards, evidence, and risks.
No. Some stem-cell products have established, FDA-approved medical uses, particularly certain blood-forming stem-cell products. However, many stem-cell products marketed for orthopedic, neurologic, cardiovascular, cosmetic, or other regenerative purposes are not approved for those uses.
Bring an accurate medication list, relevant diagnoses, prior imaging or test results when available, details of previous treatments, allergies, and the names of clinicians involved in your current care. This helps the clinical team evaluate your situation more completely.
Suitability depends on the condition being considered, your medical history, current treatments, available evidence, the exact product, its regulatory status, and the balance of potential benefit and risk. A personalized medical evaluation is necessary.
Start with a conversation, not a promise.
If you are exploring stem cell or exosome therapy, begin by asking the right clinical and regulatory questions. Schedule a consultation to discuss your goals and what next steps may be appropriate.
